Breast Implantation Completed Phase 4 Trials for Cefazolin (DB01327)

IndicationStatusPhase
DBCOND0050374 (Breast Implantation)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01244698Postoperative Antibiotic Requirements Following Immediate Breast ReconstructionTreatment